drugset / Press release
Ultragenyx Advances Clinical Development of UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
2013-05-15 · Ultragenyx Pharmaceutical Inc · original ultragenyx.com ↗
Ultragenyx Advances Clinical Development of UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
The release as fetched from its publisher. ultragenyx.com ↗